The pharmacologic basis for the treatment of developmental and acute laminitis.
Authors: Belknap
Journal: The Veterinary clinics of North America. Equine practice
Summary
# Editorial Summary: The Pharmacologic Basis for Treatment of Developmental and Acute Laminitis Laminitis management has long been hampered by uncertainty surrounding disease mechanisms, leading to inconsistent and often ineffective treatment protocols across equine practice. Belknap's 2010 review synthesises recent pathophysiological research to establish a scientific framework for understanding how various pharmacological interventions actually work at tissue level, rather than relying on empirical tradition. The article maps current treatment options—including NSAIDs, vasodilators, anti-endotoxaemic agents, and digital hypothermia—against emerging understanding of the inflammatory cascades, lamellar microvascular dysfunction, and enzymatic degradation that characterise both developmental (grain overload, sepsis-related) and acute laminitis. By grounding pharmaceutical choices in validated pathophysiology, the review enables practitioners to make evidence-based decisions about drug combinations and timing rather than defaulting to generic protocols. This shift from 'standard' to mechanism-informed treatment represents a significant opportunity for improving outcomes, particularly when tailoring intervention intensity and duration to individual cases and stages of disease.
Read the full abstract on PubMed
Practical Takeaways
- •Treatment decisions for laminitis should be based on current scientific understanding of disease mechanisms rather than traditional or empirical approaches
- •Both developmental and acute laminitis presentations require pharmacologic consideration, likely with different therapeutic targets and timing
- •Understanding the pathophysiology underlying different laminitis cases can guide selection among available treatment options
Key Findings
- •Recent advances in laminitis research have significantly improved understanding of disease pathophysiology compared to previous decades of confusion and controversy
- •Pharmacologic treatment approaches for laminitis should be informed by and contextualized within current scientific understanding of the disease process
- •Multiple treatment options exist for laminitis management, differentiated by their relevance to specific pathophysiologic mechanisms